AORT
Artivion, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.3% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -9 | 30.79M | $692.37M | +4 | −14 |
| Q1 2026 | 90 | -2 | 28.88M | $1.06B | +3 | −5 |
| Q4 2025 | 92 | +1 | 30.30M | $1.38B | +1 | — |
| Q3 2025 | 16 | 0 | 19.46M | $824.05M | — | — |
| Q2 2025 | 13 | -1 | 15.74M | $489.42M | — | −1 |
| Q1 2025 | 11 | +2 | 4.47M | $109.76M | +4 | −2 |
| Q4 2024 | 9 | 0 | 4.55M | $130.11M | +2 | −2 |
| Q3 2024 | 8 | -1 | 2.82M | $75.02M | — | −1 |
| Q2 2024 | 9 | — | 3.19M | $81.86M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 1.66M | +0.2% | $47.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.66M | +0.2% | $47.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.66M | +0.2% | $47.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.66M | +0.2% | $47.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.66M | +0.2% | $47.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.66M | +0.2% | $47.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 1.55M | — | $44.19M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 872.07K | -1.0% | $24.94M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passief) | 872.07K | -1.0% | $24.94M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 194.92K | Nieuw | $5.57M | 0.0% | New | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 165.48K | +25.1% | $4.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 39.49K | +11.1% | $1.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 32.23K | +21.7% | $921,457 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 32.23K | +21.7% | $921,457 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 32.23K | +21.7% | $921,457 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 32.23K | +21.7% | $921,457 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 30.52K | -12.9% | $872,710 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 10.09K | Nieuw | $288,387 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $5.57M | 0.0% |
| Arrowstreet Capital | $288,387 | 0.0% |
Verlaten
| Citadel Advisors | $686,530 | was 0.0% |
| Two Sigma Investments | $685,731 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 237 houders, 44.31M aandelen, $1.58B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 70.00K aand · $2.03M
Officer · 715 aand · $20,413
Officer · 616 aand · $17,586
Officer · 977 aand · $27,835
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie